New Year, New Normal – and, of course, AI.

Dear Readers,

There is something peculiar about the first days of a new year. The calendar reliably fills up again with appointments, meetings, and deadlines—and yet, there is sometimes that brief moment where one genuinely believes things can change. New routines. Better habits. Perhaps even a more conscious approach to one’s own health. Between New Year’s resolutions and the first mandatory appointments, I ask myself every year: What am I truly taking with me into the new year—and what is better left where it belongs: in the last one?

It was with exactly this mixture of curiosity and healthy skepticism that I looked at the digital health innovations of CES 2026. One wants to remain open to new things—while simultaneously wondering which of them will still be relevant by Easter and which will have quietly vanished from one’s app overview long before then.

The good news first: In 2026, Digital Health feels significantly more “grown-up” than it did just a few years ago. Wearables, diagnostic solutions, and health platforms have become quieter. And that is precisely their greatest progress. Apple, Samsung, and Google largely moved away from grand health “showstoppers,” focusing instead on incremental improvements: more precise sleep analysis, more stable stress tracking, and better integration into existing platforms. Unspectacular? Yes. But probably exactly what health needs. It is no longer being revolutionarily reinvented—it is being quietly and continuously improved.


From Data Fetishism to Meaningful Trends

As always, a look at the specialized providers was exciting. Oura showcased a new generation of rings with a stronger focus on metabolic health and long-term trends. Garmin pushed cardiovascular monitoring and load management closer to clinical-grade questions. The market is visibly moving away from a daily “data fetish” toward longer timeframes and more meaningful benchmarks and analyses.

This represents a massive opportunity, especially for prevention. At the same time, the risk of “silent overwhelm” is growing. The more we measure continuously, the greater the need for explanation. Data without context is of little help, no matter how elegantly it is visualized.

Another focus of CES 2026 was once again Home Diagnostics. Providers like Vivoo presented advanced tests that combine multiple biomarkers and enrich their results—naturally—with AI-supported recommendations. Added to this were new blood analysis concepts for home use, sitting somewhere between lifestyle optimization and medical ambition. The line is thinning—and with it, the responsibility of the manufacturers is growing.

Particularly interesting are solutions like the evolved health mirror “Omnia” by Withings. Here, health literally gains a physical place in the room—no longer just one app among many, but a daily point of reference in a location that is an integral part of one’s daily routine. Strategically clever. At the same time, the uncomfortable question remains: Do such integrated health hubs really reach the general population—or primarily a well-meaning, wealthy, tech-savvy audience?


The Reality Check for AI

And then, of course, there is Artificial Intelligence.

Hardly a product or platform at CES 2026 could do without it. AI analyzes, predicts, prioritizes, reassures—and sometimes, it simply seems to be marketing. Whether it’s a wearable, a home test, or a health dashboard: AI is inside everything, often so naturally that one almost forgets to ask what it actually makes better.

The oft-cited AI bubble was certainly hard to miss. While some providers are seriously working on explainable, medically resilient models—for example, based on platforms like NVIDIA Clara—others content themselves with high-sounding promises and little transparency. In 2026, AI is a requirement, not a differentiator. It’s becoming harder to truly impress anyone with it.

Perhaps that is the actual signal of this CES. The industry seems to sense that the “AI magic” won’t last forever. The closer digital solutions move to medical decision-making, the less a “built with AI” sticker suffices. Explainability, liability, and responsibility are moving to the forefront—entirely without the buzzwords.

Conclusion: Less “Smart,” More Meaningful

CES 2026 shows a Digital Health world that has arrived and must now prove its worth. The opportunities clearly lie in networked prevention, continuous support, and new care models. The risks are equally clear: overwhelm, lack of transparency, and an AI euphoria that promises more than it can deliver.

Perhaps that fits quite well with January. Fewer resolutions, more realism. Less “smart,” more meaningful.

My wish for the new year: That in the digital health sector, we don’t just want to measure more and more, but that we want to—and will—understand better. That technology is not an end in itself but creates real added value in daily (healthcare) life. And that those solutions prevail which are allowed to stay because they work—not because they were particularly loud at CES.

And if, while reading this, you feel the urge to critically review your own health apps and consider which ones really deserve to stay—then you feel just like I do.

Until next time—and with best wishes for a healthy New Year 2026.

Yours,

Torsten Christann

Free Download

Please complete the following data to download the Advanced Diabetes Technology Landscape 2025.

Your Contact

Torsten Christann
Managing Partner

diabetes@diox.de
+49 172 / 4543310